John D. Roache, Ph.D
Professor of Psychiatry and Pharmacology and Chief of the Division of Alcohol and Drug Addiction in the Department of Psychiatry at Ut Health Science Center
Chief of the Division of Alcohol and Drug Addiction, Department of Psychiatry
Ut Health Science Center
Biographical Sketch
John D. Roache, Ph.D. is a Professor of Psychiatry and Pharmacology and Chief of the Division of Alcohol and Drug Addiction in the Department of Psychiatry. He also serves as the Director of clinical trials operations of the Institute on the Integration of Medicine & Science (IIMS) FIRST Program and Deputy Director of the STRONG STAR PTSD Research Consortium and the Consortium to Alleviate PTSD (CAP). His research interests are in understanding the behavioral neurobiology of the causes, consequences, and treatments for alcohol and drug addiction.
Education
Year | Degree | Major | Institution |
---|---|---|---|
1987 | Postdoctoral Fellowship | Clinical Pharmacology Research | Addiction Research Center, National Institute on Drug Abuse Baltimore , MD |
1985 | Postdoctoral Fellowship | Department of Psychiatry & Behavioral Sciences | The Johns Hopkins University School of Medicine Baltimore , MD |
1983 | PhD | Pharmacology & Toxicology | Purdue University West Lafayette , IN |
1980 | MS | Pharmacology & Toxicology | Purdue University West Lafayette , IN |
1977 | BS | Biology | Indiana University Bloomington , IN |
Presentations/Publications with the NRLC
-
The role of social support in motivating reductions in alcohol use: Tests of three models of social support in alcohol impaired drivers
Alcoholism: Clinical and Experimental Research, 43, 123-134.
- Time Delays in Transdermal Alcohol Concentrations Relative to Breath Alcohol Concentrations
- The correspondence between transdermal alcohol monitoring and daily self-reported alcohol consumption
- The potential clinical utility of transdermal alcohol monitoring data to estimate the number of alcoholic drinks consumed
-
Using contingency management procedures to reduce at-risk drinking in heavy drinkers
Alcoholism: Clinical and Experimental Research, 39, 109-121.
-
Characterization of the pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in human whole blood after alcohol consumption in a clinical laboratory study.
Alcoholism: Clinical and Experimental Research, 40, 1228-1234.
- Behavioral impulsivity does not predict naturalistic alcohol consumption or treatment outcomes
- Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking
- Effects of tryptophan depletion and a simulated alcohol binge on impulsivity.
- Accounting for sex-related differences in the estimation of breath alcohol levels using transdermal alcohol monitoring
- Assessing the validity of participant-derived compared to staff-derived values to compute a binge score
-
Using transdermal alcohol monitoring to detect low-level drinking
Alcoholism: Clinical & Experimental Research, 39, 1120-1127.
- Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.
-
Do variable rates of alcohol drinking alter the ability to use transdermal alcohol monitors to estimate peak breath alcohol and total number of drinks?
Alcoholism: Clinical and Experimental Research, 38, 2517-2522.
- Accounting for sex-related differences in the estimation of breath alcohol concentrations using transdermal alcohol monitoring
- Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter.